Copenhagen, Denmark-based 3Shape reported that San Jose, Calif.-based Align Technology Inc. has asked that the entire District Court case DC 1649 be dismissed, along with a patent from the DC 1950 case, thereby giving up its previous assertion of a total of eight patents against 3Shape in the Delaware litigations. At the same time, it noted that Align filed a new lawsuit against 3Shape in the U.S. District Court for the Western District of Texas alleging infringement of seven patents. It noted that six of the seven patents asserted against 3Shape in this latest filing belong to the same patent families of Align patents which have been determined to be invalid by one or more U.S. courts. In addition to defending itself against Align’s litigation, 3Shape has a case pending against Align for infringement of 3Shape patents, 24 petitions to address the invalidity of several Align patents, and an antitrust lawsuit to address what it claims is Align’s abuse of monopoly power. 3Shape’s patent infringement and antitrust lawsuits are currently pending in Delaware.

Irvine, Calif.-based Agendia Inc. reported that the Federal Joint Committee (G-BA) has approved Mammaprint, Agendia's 70-Gene Breast Cancer Recurrence Assay. The G-BA decision to reimburse will broaden access to all breast cancer patients in Germany. Mammaprint analyzes 70 genes most associated with breast cancer recurrence to provide a binary Low or High Risk of cancer recurrence result.

Guided Therapeutics Inc., of Peachtree Corners, Ga, reported the successful outcome of its Oct. 14, meeting with FDA. The purpose of the meeting was to finalize the protocol for its new clinical study in support of its premarket approval for the Luviva advanced cervical scan. The company filed the minutes from this meeting with FDA on Oct 20, which the agency will review and provide any final comments on the meeting and study protocol.

Hatch Medical LLC, of Santa Rosa Beach, Fla., is partnering with Vascutech Medical LLC, of Phoenixville, Pa., to commercialize their next-generation radial sheath and micro-introducer lines technologies.

Infinity Biologix LLC (IBX), of Piscataway, N.J., and New York-based Vault Health have collaborated with the State of Minnesota to launch a saliva testing lab in Oakdale, Minn. The IBX COVID saliva lab will be capable of processing up to 30,000 samples a day when operating at full capacity and will employ up to 250 Minnesotans. Vault Health developed the at-home and on-site COVID saliva testing platform, while IBX developed the saliva test.

Precision Genetics Inc., of Greenville, S.C., has added saliva collection to its portfolio of validated COVID-19 testing options submitted under emergency use authorization by the U.S. FDA.

London-based Rldatix Ltd., a provider of software-based patient safety solutions, has acquired Verge Health, of Mount Pleasant, S.C., a credentialing software provider. The deal, terms of which were not disclosed, is expected to accelerate adoption of Rldatix’s Applied Safety Intelligence framework and create an industry standard for proactive risk mitigation.

Amsterdam-based Royal Philips NV and Marienhospital Stuttgart, Germany, have inked a 10-year agreement to improve patient care and efficiency at the hospital. The project will include renewal and ongoing development of the hospital’s diagnostic imaging equipment and associated IT systems, digitization of its pathology department and enhancement of emergency medicine capabilities.

Amsterdam-based Royal Philips NV said that Simonmed Imaging, a Scottsdale, Ariz.-based outpatient imaging provider, will bring the most advanced 3T MRI Philips technology to its centers of excellence across the U.S. Philips and Simonmed also are collaborating to further enhance the patient experience and speed in diagnostic imaging.

Teladoc Health Inc., which has a Canadian presence in Toronto, reported the launch of Mental Health Care, its new telemedicine service enabling employees in Canada to count on access to psychiatrists, psychologists and therapists from the convenience of their phone, web or mobile app. According to the company, the new service also creates the first telemedicine solution to offer both general medical and mental health care from the same platform, enabling a more holistic and seamless approach to care.

Telus Health, which is headquartered in Montréal, reported the launch of Espri by Telus Health, a mobile app that delivers mental health and wellness resources to support the rising mental health pressures faced by physicians, nurses, care workers, emergency medical services, firefighters, police, correctional officers and their family members.